Orchestra BioMed
OBIO
OBIO
48 hedge funds and large institutions have $121M invested in Orchestra BioMed in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 50 → 48 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
48
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.2M | |
| 2 | +$1.15M | |
| 3 | +$989K | |
| 4 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$979K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$792K |
Top Sellers
| 1 | -$2.45M | |
| 2 | -$1.2M | |
| 3 | -$1.02M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$912K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$758K |